Journal of Clinical Pharmacy and Therapeutics 2005: Vol 30 Index

2005·1.3 MB·English

Journal of Clinical Pharmacy and Therapeutics (2005) 30, 627-631
AUTHOR INDEX
Abdollahi, M. see Salari, P. Brique, S. see Odou, P.
Aghayan, S. see Amini, H. Britten, N. see Barber, N.
Agnew, L.L., Guffogg, S.P., Matthias, A., Lehmann, R.P., Bone, Brown, N.S. see Kroese, W.L.G.
K.M. & Watson, K. Echinacea intake induces an immune Brunhes, A. see Desfrere, L.
response through altered expression of leucocyte hsp70, Bryan, S. see Greenfield, S.
increased white cell counts and improved erythrocyte anti- Burnier Jr, M.N. see Ventura, M.P.
oxidant defences, 363 Bush, N. see Griffiths, L.
Akhondzadeh, S. see Amini, H. Bush, T.M. see Chung, L.
Allgood, L.D., Grender, J.M., Shaw, M.J. & Peura, D.A. Compar- Buzdar, A.U. see Yamaya, H.
ison of Prilosec OTC™ (omeprazole magnesium 20.6 mg) to
placebo for 14 days in the treatment of frequent heartburn, 105
Caliendo, G.C. see Cheng, J.W.M.
Al-Nasan, A. see Arafat, T.
Calvo, M.V. see Lukas, J.C.
Amin, A.A., Snow, R.W. & Kokwaro, G.O. The quality of Calvo, R. see Lukas, J.C.
sulphadoxine-pyrimethamine and amodiaquine products in Chabot, I. see Coté, I.
the Kenyan retail sector, 559 Chakravarty, E.F. see Chung, L.
Amini, H., Aghayan, S., Jalili, S.A., Akhondzadeh, S., Yahyaza- Chan, K. see Lindsay, M.
deh, O. & Pakravan-Nejad, M. Comparison of mirtazapine Chang, J.-G. see Lu, H.-F.
and fluoxetine in the treatment of major depressive disorder: Chang, J.-Y. see Lu, H.-F.
a double-blind, randomized trial, 133
Charnock, C., Finsrud, T. & Foss, C. Controlling the proliferation
Anderson, P.J. see Critchley, J.A.J.H. of Zygosaccharomyces bailii in ephedrine anti-phlegm cough
Arafat, T., Awad, R., Hamad, M., Azzam, R., Al-Nasan, A., mixture, 329
Jehanli, A. & Matalka, K. Pharmacokinetics and pharmaco- Chen, C.-M. see Lu, H.-F.
dynamics profiles of enalapril maleate in healthy volunteers Chen, K., Wang, R., Wen, S.-Y., Li, J. & Wang, S.-Q. Relationship
following determination of enalapril and enalaprilat by two of P450 2C9 genetic polymorphisms in Chinese and the
specific enzyme immunoassays, 319 pharmacokinetics of tolbutamide, 241
Armstrong, D. see Griffiths, L.
Chen, S.-W., Hwang, W.-S., Tsao, C.-J., Liu, H.-S. & Huang, G.-C.
Avery, A.J. see Kroese, W.L.G. Hydroxyurea and splenic irradiation-induced tumour lysis
Awad, R. see Arafat, T. syndrome: a case report and review of the literature, 623
Azzam, R. see Arafat, T. Cheng, J.W.M., Merl, M.Y., Nguyen, H.M., Caliendo, G.C. &
Meyers, J. Nesiritide utilization evaluation in a university
Bahaadini, K. see Salari, P. teaching hospital, 447
Baloglu, E. see Pamir, T. Cheung, B.M.Y., Wong, Y.L. & Lau, C.P. Queen Mary Utilization
Barber, N., Bradley, C., Barry, C., Stevenson, F., Britten, N. & of Antihypertensive Drugs Study: side-effects of anti-
Jenkins, L. Measuring the appropriateness of prescribing in hyperiensive drugs, 391
primary care: are current measures complete?, 533 Chevret, S. see Desfrere, L.
Barry, C. see Barber, N. Chevret, S. see Treluyer, J.-M.
Barthélémy, C. see Odou, P. Chiadmi, F., Daroso, J., Schlatter, J., Cisternino, S., Ratiney, R. &
Behan, K., Cutts, C. & Tett, S.E. Motivations and perceived Fontan, J.E. Stability of doxorubicin combined with Radio-
influences on rural and urban general practitioners when selectan®, a contrast agent, for chemoembolization, 255
prescribing conventional non-steroidal anti-inflammatory Chongsuvivatwong, V. see Janchawee, B.
drugs or COX-2 inhibitors, 337 Choo, C.L. see Jenkins, B.G.
Beniowski, M. see Marek, B. Chui, W.K. & Li, S.C. Advice-giving on self-medication:
Beppler, G.A. see Craig, M.A. perspectives of community pharmacists and consumers in
Bereznicki, L.R. see Jackson, S.L. Singapore, 225
Berger, K., Eickhoff, C. & Schulz, M. Counselling quality in Chung, L., Chakravarty, E.F., Kearns, P., Wang, C. & Bush, T.M.
community pharmacies: implementation of the pseudo cus- Bleeding complications in patients on celecoxib and warfarin,
tomer methodology in Germany, 45 47]
van den Bergh, W.M. see van Norden, A.G.W. Cisternino, S. see Chiadmi, F.
Berkovitch, M. see Greenberg, R. Coffiner, M. see Malonne, H.
Bielecka-Grzela, S. & Klimowicz, A. Penetration of ciprofloxacin Coleman, J.J. Presenting information on risks, 511
and its desethylenemetabolite into skin in humans after a Cooke, C.A. see Whelan, A.M.
single oral dose of the parent drug assessed by cutaneous Coté, I., Moisan, J., Chabot, I. & Grégoire, J.-P. Health-related
microdialysis, 383 quality of life in hypertension: impact of a pharmacy inter-
Bies, R.R. see Kane-Gill, S.L. vention programme, 355
Bobek, M.B. see Kane-Gill, S.L. Craig, M.A., Beppler, G.A., Santos, C. & Raffa, R.B. A second
Bone, K.M. see Agnew, L.L. (non-genomic) steroid mechanism of action: possible oppor-
Borgiel-Marek, H. see Marek, B. tunity for novel pharmacotherapy?, 305
Botta, C. see Pourroy, B. Critchiey, J.A.J.H., Critchley, L.A.H., Anderson, P.J. & Tomlin-
Bradley, C. see Barber, N. son, B. Differences in the single-oral-dose pharmacokinetics
Braguer, D. see Pourroy, B. and urinary excretion of paracetamol and its conjugates
Braun, U. see Poon, I.O. between Hong Kong Chinese and Caucasian subjects, 179
© 2005 Blackwell Publishing Ltd 627
628 AUTHOR INDEX
Critchley, L.A.H. see Critchley, J.A.J.H. Hadavand, N. see Salari, P.
Cuadrado, J.M. see Jover, F. Hamad, M. see Arafat, T.
Cutts, C. see Behan, K. Han, L.K. see Lindsay, M.
Hansen, E.H. see Nielsen, M.W.
Daroso, J. see Chiadmi, F. Hasegawa, R. see Saito, M.
Dasta, J.F. see Kane-Gill, S.L. Hebron, Y., Tettey, J.N.A., Pournamdari, M. & Watson, D.G. The
chemical and pharmaceutical equivalence of sulphadoxine/
Daubert, G.P. The white clot syndrome, 503
Daugherty, K.K. Samples: to use or not to use?, 505 pyrimethamine tablets sold on the Tanzanian market, 575
Dautzenberg, M.G.H. see Denneboom, W. Heiser, P. see Wehmeier, P.M.
De Smet, P.A.G.M. see Denneboom, W. Helin-Salmivaara, A., Huupponen, R., Virtanen, A. & Klaukka,
Denneboom, W., Dautzenberg, M.G.H., Grol, R. & De Smet, T. Adoption of celecoxib and rofecoxib: a nationwide database
P.A.G.M. User-related pharmaceutical care problems and study, 145
factors affecting them: the importance of clinical relevance, Hill, C. see Martin, U.
215 Hing, W.C., Yeoh, T.T., Yeoh, S.F., Lin, R.T.P. & Li, S.C. An
Desfrere, L., Zohar, S., Morville, P., Brunhes, A., Chevret, S., evaluation of antimicrobial prophylaxis in paediatric surgery
Pons, G., Moriette, G., Rey, E. & Treluyer, J.M. Dose-finding and its financial implication, 371
study of ibuprofen in patent ductus arteriosus using the Hippisley-Cox, J. see Kroese, W.L.G.
continual reassessment method, 121 Hirata-Koizumi, M. see Saito, M.
Dollman, W.B., LeBlanc, V.T., Stevens, L., O’Connor, P.J., Hirooka, K. see Saito, M.
Roughead, E.E. & Gilbert, A-L. Achieving a sustained reduc- Honda, K. see Nagashima, A.
tion in benzodiazepine use through implementation of an Hong, S.H., Spadaro, D., West, D. & Tak, S.H. Patient valuation
area-wide multi-strategic approach, 425 of pharmacist services for self care with OTC medications, 193
Horsfield, P. see Kroese, W.L.G.
Howard, R. see Kroese, W.L.G.
Eickhoff, C. see Berger, K.
Hsueh, S.-C. see Lu, H.-F.
El-Solh, A.A. see Ramadan, F.H.
Huang, G.-C. see Chen, S.-W.
Huang, Y.-H. see Ren, X.S.
Feng, Y. see Kane-Gill, S.L. Hubert, P. see Treluyer, J.-M.
Ferrari, N. see Odou, P. Hughes, C.M. see Wazaify, M.
Fila, A. see Marek, B. Huupponen, R. see Helin-Salmivaara, A.
Filipczyk, P. see Marek, B. Hwang, W.-S. see Chen, S.-W.
Finsrud, T. see Charnock, C.
Fontaine, D. see Malonne, H.
Imamura, T. see Fukuda, T.
Fontan, J.E. see Chiadmi, F.
Inomata, S. see Nagashima, A.
Foss, C. see Charnock, C.
Irie, T. see Fukuda, T.
Fujita, T., Yokota, S., Sawada, M., Majima, M., Ohtani, Y. &
Irikura, M. see Fukuda, T.
Kumagai, Y. Effect of MKC-733, a 5-HT3 receptor partial
Iserin, F. see Treluyer, J.-M.
agonist, on bowel motility and symptoms in subjects with
Ishii, T. see Ozaki, H.
constipation: an exploratory study, 611
Ishikawa, T. see Ozaki, H.
Fukuda, T., Yukawa, E., Kondo, G., Maeda, T., Shin-o, T., Kondo,
Ismail, R. see Muthiah, Y.D.
Y., Imamura, T., Irikura, M. & Irie, T. Population pharmaco-
Isobe, F. see Saito, M.
kinetics of theophylline in very premature Japanese infants
with apnoea, 591
Jackson, S.L., Peterson, G.M., Bereznicki, L.R., Misan, G.M.., Jupe,
D.M.L. & Vial, J.H. Improving the outcomes of anti-
Gil, A.D. see Lukas, J.C.
coagulation in rural Australia: an evaluation of pharmacist-
Gilbert, A.L. see Dollman, W.B.
assisted monitoring of warfarin therapy, 345
Gill, P. see Greenfield, S.
Jalili, S.A. see Amini, H.
Girard, T. see Li Wan Po, A. Janchawee, B., Owatranporn, T., Mahatthanatrakul, W. &
Girard, T. Dosing of midazolam in neonates, 423
Chongsuvivatwong, V. Clinical drug interactions in out-
Goldstein, L. see Greenberg, R.
patients of a university hospital in Thailand, 583
Goto, T. see Takada, M.
Janchawee, B., Wongpoowarak, W., Owatranporn, T. & Chong-
Greenberg, R., Grossman, Z., Goldstein, L., Berkovitch, M. &
suvivatwong, V. Pharmacoepidemiologic study of potential
Kozer, E. How much acetaminophen do paediatricians pre-
drug interactions in outpatients of a university hospital in
scribe? A survey among Israeli paediatricians, 443
Thailand1,3
Greenfield, S., Bryan, S., Gill, P., Gutridge, K. & Marshall, T.
Janczewska-Kazek, E. see Marek, B.
Factors influencing clinicians’ decisions to prescribe medica-
Jehanli, A. see Arafat, T.
tion to prevent coronary heart disease, 77
Jenkins, B.G., Tuffin, P.H.R., Choo, C.L. & Schug, S.A. Opioid
Grégoire, J.-P. see Coté, I.
prescribing: an assessment using quality statements, 597
Grender, J.M. see Allgood, L.D.
Jenkins, L. see Barber, N.
Griffiths, L., Bush, N., Mottram, D. & Armstrong, D. A study of
Jittangtrong, J. see Poolsup, N.
the management of erectile dysfunction in general practice,
Jover, F., Cuadrado, J.M. & Merino, J. Possible azithromycin-
297
associated hiccups, 413
Grol, R. see Denneboom, W.
Jugie, M. see Treluyer, J.-M.
Grossman, Z. see Greenberg, R.
Jupe, D.M.L. see Jackson, S.L.
Guffogg, S.P. see Agnew, L.L.
Gundgaard, J. see Nielsen, M.W.
Gunji, T. see Takada, M. Kajdaniuk, D. see Marek, B.
Gutridge, K. see Greenfield, S. Kajdaniuk, J. see Marek, B.
© 2005 Blackwell Publishing Ltd, Journal of Clinical Pharmacy and Therapeutics, 30, 627-631
AUTHOR INDEX 629
Kane-Gill, S.L., Feng, Y., Bobek, M.B., Bies, R.R., Pruchnicki, Lohitnavy, O. see Lohitnavy, M.
M.C. & Dasta, J.F. Administration of enoxaparin by con- Lu, H.-F., Shih, M.-C., Hsueh, S.-C., Chen, C.-M., Chang, J.-Y. &
tinuous infusion in a naturalistic setting: analysis of renal Chang, J.-G. Molecular analysis of the thiopurine S-methyl-
function and safety, 207 transferase alleles in Bolivians and Tibetans, 491
Kang, W. see Yun, H.-Y. Lukas, J.C., Suarez, A.M., Valverde, M.P., Calvo, M.V., Lanao,
Kang, W.K., Yun, H.-Y. & Kwon, K.-I. Assessing the bioequi- J.M., Calvo, R., Suarez, E. & Gil, A.D. Time-dependent phar-
valence of 4- and 8-mg benidipine tablets in healthy volun- macokinetics of cyclosporine (Neoral”) in de novo renal
teers after a single oral dose, 85 transplant patients, 549
Kawato, N. see Takada, M.
Kazis, L. see Ren, X.S. McElnay, J.C. see Wazaify, M.
Kearns, P. see Chung, L.
Maeda, T. see Fukuda, T.
Kennedy, S. see Wazaify, M. Mahatthanatrakul, W. see Janchawee, B.
Khanthong, M. see Poolsup, N. Mahatthanatrakul, W. see Ridtitid, W.
Kinoshita, H. see Yukawa, E. Majima, M. see Fujita, T.
Klaukka, T. see Helin-Salmivaara, A. Malonne, H., Coffiner, M., Fontaine, D., Sonet, B., Sereno, A.,
Klimowicz, A. see Bielecka-Grzela, S. Peretz, A. & Vanderbist, F. Long-term tolerability of tramadol
Kokwaro, G.O. see Amin, A.A. LP, a new once-daily formulation, in patients with osteoar-
Kondo, G. see Fukuda, T. thritis or low back pain, 113
Kondo, Y. see Fukuda, T. Marek, B., Kajdaniuk, D., Mazurek, U., Janczewska-Kazek, E.,
Kos-Kudla, B. see Marek, B. Kos-Kudla, B., Strzalka, B., Fila, A., Niedziolka, D., Beniowski,
Kotake, T. see Takada, M. M., Ostrowska, Z., Borgiel-Marek, H., Kajdaniuk, J.,
Kozer, E. see Greenberg, R. Sieminska, L., Nowak, M., Wilczok, T., Pakula, D. & Filipezyk,
Kroese, W.L.G., Avery, A.J., Savelyich, B.S.P., Brown, N.S., P. TGF-f1 mRNA expression in liver biopsy specimens and
Schers, H., Howard, R., Hippisley-Cox, J. & Horsfield, P. TGF-f1 serum levels in patients with chronic hepatitis C
Assessing the accuracy of a computerized decision support before and after antiviral therapy, 271
system for digoxin dosing in primary care: an observational Marshall, T. see Greenfield, S.
study, 279
Martin, U., Hill, C. & O° Mahony, D. Use of moxonidine in
Kumagai, Y. see Fujita, T. elderly patients with resistant hypertension, 433
Kuritani, J. see Yamaya, H. Masoodi, N. see Ramadan, F.H.
Kwon, K.-I. see Kang, W.K. Matalka, K. see Arafat, T.
Kwon, K.-I. see Yun, H.-Y. Matthias, A. see Agnew, L.L.
May, D.B. see Pound, M.W.
Lacarelle, B. see Pourroy, B. Mazurek, U. see Marek, B.
Lanao, J.M. see Lukas, J.C. Merino, J. see Jover, F.
Lau, C.P. see Cheung, B.M.Y. Merl, M.Y. see Cheng, J.W.M.
LeBlanc, V.T. see Dollman, W.B. Meyers, J. see Cheng, J.W.M.
Lee, A. see Lindsay, M. Miller, D.R. see Ren, X.S.
Lee, A.F. see Ren, X.S. Minemoto, M. see Yukawa, E.
Lee, W.L. see Muthiah, Y.D. Misan, G.M. see Jackson, S.L.
Leelasangaluk, V. see Poolsup, N. Misawa, S. see Nagashima, A.
Lehmann, R.P. see Agnew, L.L. Miyake, S. see Saito, M.
Lenclen, R. see Treluyer, J.-M. Miyashita, Y. see Ozaki, H.
Leone, H. & Polsonetti, B.W. Amantadine for traumatic Moharreri, M. see Salari, P.
brain injury: does it improve cognition and reduce Moisan, J. see Coté, I.
agitation?, 101 Mojtahedzadeh, M. see Salari, P.
Lhermitte, M. see Odou, P. Moriette, G. see Desfrere, L.
Li Wan Po, A. & Girard, T. Succinylcholine: still beautiful and Morville, P. see Desfrere, L.
mysterious after all these years, 497 Mottram, D. see Griffiths, L.
Li Wan Po, A. Drug evaluation, drug development and phar- Murano, T. see Ozaki, H.
macogenetics: celebrating 30 years of progress, 1 Muthiah, Y.D., Lee, W.L., Teh, L.K., Ong, C.E. & Ismail, R.
Li Wan Po, A. Drug-drug interactions and adverse drug reac- Genetic polymorphism of CYP2C8 in three Malaysian
tions: the bollards and flashing lights syndrome, 97 ethnics: CYP2C8*2 and CYP2C8*3 are found in Malaysian
Li, J. see Chen, K. Indians, 487
Li, S.C. see Chui, W.K.
Li, S.C. see Hing, W.C. Nagashima, A., Tanaka, E., Inomata, S., Honda, K. & Misawa, S.
Libersa, C. see Odou, P. A study of the in vitro interaction between lidocaine and
Lin, R.T.P. see Hing, W.C. premedications using human liver microsomes, 185
Lindsay, M., Lee, A., Chan, K., Poon, P., Han, L.K., Wong, Nagayama, S. see Yamaya, H.
W.C.W. & Wong, S. Does pulmonary rehabilitation give Najafi, A. see Salari, P.
additional benefit over tiotropium therapy in primary care Nakai, M. see Takada, M.
management of chronic obstructive pulmonary disease? Naunton, M. see Peterson, G.M.
Randomized controlled clinical trial in Hong Kong Chinese, Nguyen, H.M. see Cheng, J.W.M.
567 Niedziolka, D. see Marek, B.
Liu, H.-S. see Chen, S.-W. Nielsen, M.W., Gundgaard, J., Hansen, E.H. & Rasmussen,
Lohitnavy, M., Lohitnavy, O., Thangkeattiyanon, O. & Srichai, N.K. Use of six main drug therapeutic groups across edu-
W. Reduced oral itraconazole bioavailability by antacid cational groups: self-reported survey and _ prescription
suspension, 201 records, 259
© 2005 Blackwell Publishing Ltd, Journal of Clinical Pharmacy and Therapeutics, 30, 627-631
630 AUTHOR INDEX
van Norden, A.G.W., van den Bergh, W.M. & Rinkel, G.J.E. Dose Raungsri, N. see Ridtitid, W.
evaluation for long-term magnesium treatment in aneurysmal Remschmidt, H. see Wehmeier, P.M.
subarachnoid haemorrhage, 439 Ren, X.S., Huang, Y.-H., Lee, A.F., Miller, D.R., Qian, S. &
Nowak, M. see Marek, B. Kazis, L. Adjunctive use of atypical antipsychotics
Nsimba, S.E.D. & Rimoy, G.H. Self-medication with chloro- and anticholinergic drugs among patients with schizo-
quine in a rural district of Tanzania: a therapeutic challenge phrenia, 65
for any future malaria treatment policy change in the Rey, E. see Desfrere, L.
country, 515 Rey, E. see Treluyer, J.-M.
Ridtitid, W., Wongnawa, M., Mahatthanatrakul, W., Raungsri,
O'Connor, P.J. see Dollman, W.B. N. & Sunbhanich, M. Ketoconazole increases plasma con-
Odou, P., Ferrari, N., Barthélémy, C., Brique, S., Lhermitte, M., centrations of antimalarial mefloquine in healthy human
Vincent, A., Libersa, C. & Robert, H. Grapefruit juice- volunteers, 285
nifedipine interaction: possible involvement of several Rimoy, G.H. see Nsimba, S.E.D.
mechanisms, 153 Rinkel, G.J.E. see van Norden, A.G.W.
Ohtani, Y. see Fujita, T. Rithlamlert, C. see Poolsup, N.
Okada, H. see Takada, M. Robert, H. see Odou, P.
Onal, B. see Pamir, T. Roughead, E.E. see Dollman, W.B.
Ong, C.E. see Muthiah, Y.D.
O° Mahony, D. see Martin, U.
Orio, K. see Yukawa, E. Sadraie, S. see Salari, P.
Saheb, N.E. see Ventura, M.P.
Ostrowska, Z. see Marek, B.
Saito, M., Hirata-Koizumi, M., Urano, T., Miyake, S. &
Owatranporn, T. see Janchawee, B.
Ozaki, H., Ishikawa, T., Ishii, T., Toyoda, A., Murano, T., Hasegawa, R. A literature search on pharmacokinetic drug
Miyashita, Y. & Shirai, K. Clearance rates of cerivastatin interactions of statins and analysis of how such interactions
metabolites in a patient with cerivastatin-induced rhabdo- are reflected in package inserts in Japan, 21
myolysis, 189 Saito, M., Takada, M., Hirooka, K., Isobe, F. & Yasumura, Y.
Ozyazici, M. see Pamir, T. Serum concentration of potassium in chronic heart failure
patients administered spironolactone plus furosemide and
either enalapril maleate, losartan potassium or candesartan
Pakravan-Nejad, M. see Amini, H.
cilexetil, 603
Pakula, D. see Marek, B.
Saito, M. see Takada, M.
Pamir, T., Ozyazici, M., Baloglu, E. & Onal, B. The efficacy of
Salari, P., Mojtahedzadeh, M., Najafi, A., Sadraie, S., Bahaadini,
three desensitizing agents in treatment of dentine hypersen- K., Moharreri, M., Hadavand, N. & Abdollahi, M. Compar-
sitivity, 73 ison of the effect of aminophylline and low PEEP vs. high
Peretz, A. see Malonne, H. PEEP on EGF concentration in critically ill patients with ALI/
Peterson, G.M. & Naunton, M. Valproate: a simple chemical ARDS, 139
with so much to offer, 417 Santos, C. see Craig, M.A.
Peterson, G.M. see Jackson, S.L.
Saraiva, \’.S. see Ventura, M.P.
Peura, D.A. see Allgood, L.D.
Savelyich, B.S.P. see Kroese, W.L.G.
Polsonetti, B.W. see Leone, H.
Sawada, M. see Fujita, T.
Pons, G. see Desfrere, L.
Schers, H. see Kroese, W.L.G.
Pons, G. see Treluyer, J.-M.
Schlatter, J. see Chiadmi, F.
Poolsup, N., Leelasangaluk, V., Jittangtrong, J., Rithlamlert, C.,
Schug, S.A. see Jenkins, B.G.
Ratanapantamanee, N. & Khanthong, M. Efficacy and toler-
Schulz, M. see Berger, K.
ability of frovatriptan in acute migraine treatment: systematic
Sereno, A. see Malonne, H.
review of randomized controlled trials, 521
Poon, I.O. & Braun, U. High prevalence of orthostatic hypoten- Shaw, M.J. see Allgood, LAD.
Shibakawa, M. see Takada, M.
sion and its correlation with potentially causative medications
Shih, M.-C. see Lu, H.-F.
among elderly veterans, 173
Shindo, T. see Yamaya, H.
Poon, P. see Lindsay, M.
Shin-o, T. see Fukuda, T.
Pound, M.W. & May, D.B. Proposed mechanisms and pre-
Shirai, K. see Ozaki, H.
ventative options of Jarisch-Herxheimer reactions, 291
Sieminska, L. see Marek, B.
Pournamdari, M. see Hebron, Y. Sing Rang:.. G. Current concepts in the endocrine therapy
Pourroy, B., Botta, C., Solas, C., Lacarelle, B. & Braguer, D.
breast r: tamoxifen and aromatase inhibitors, 313
Seventy-two-hour stability of Taxol” in 5% dextrose or 0.9%
Sketris, 1.S. see Whelan, A.M.
sodium chloride in Viaflo”, Freeflex”, Ecoflac® and Macoflex
Snow, R.W. see Amin, A.A.
N® non-PVC bags, 455
Solari, H.P. see Ventura, M.P.
Pruchnicki, M.C. see Kane-Gill, S.L.
Solas, C. see Pourroy, B.
Sonet, B. see Malonne, H.
Qian, S. see Ren, X.S. Spadaro, D. see Hong, S.H.
Srichai, W. see Lohitnavy, M.
Raffa, R.B. see Craig, M.A. Stevens, L. see Dollman, W.B.
Ramadan, F.H., Masoodi, N. & El-Solh, A.A. Clinical factors Stevenson, F. see Barber, N.
associated with hyperkalemia in patients with congestive Strzalka, B. see Marek, B.
heart failure, 233 Suarez, A.M. see Lukas, J.C
Rasmussen, N.K. see Nielsen, M.W. Suarez, E. see Lukas, J.C.
Ratanapantamanee, N. see Poolsup, N. Suematsu, F. see Yukawa, E.
Ratiney, R. see Chiadmi, F. Sunbhanich, M. see Ridtitid, W.
© 2005 Blackwell Publishing Ltd, Journal of Clinical Pharmacy and Therapeutics, 30, 627-631
AUTHOR INDEX 631
Tak, S.H. see Hong, S.H. Accident and Emergency departments in Northern Ireland —a
Takada, M., Goto, T., Kotake, T., Saito, M., Kawato, N., Nakai, retrospective evaluation, 39
M., Gunji, T. & Shibakawa, M. Appropriate dosing of antiar- Wehmeier, P.M., Heiser, P. & Remschmidt, H. Myocarditis,
rhythmic drugs in Japan requires therapeutic drug monitor- pericarditis and cardiomyopathy in patients treated with
ing, 5 clozapine, 91
Takada, M., Okada, H., Kotake, T., Kawato, N., Saito, M., Nakai, Wen, S.-Y. see Chen, K.
M., Gunji, T. & Shibakawa, M. Appropriate dosing regimen of West, D. see Hong, S.H.
allopurinol in Japanese patients, 407 Whelan, A.M., Cooke, C.A. & Sketris, 1S. The impact of socio-
Takada, M. see Saito, M. economic and demographic factors on the utilization of
Tanaka, E. see Nagashima, A. smoking cessation medications in patients hospitalized with
Teh, L.K. see Muthiah, Y.D. cardiovascular disease in Nova Scotia, Canada, 165
Terao, K. see Yukawa, E. Wilczok, T. see Marek, B.
Tett, S.E. see Behan, K. Wong, S. see Lindsay, M.
Tettey, J.N.A. see Hebron, Y. Wong, W.C.W. see Lindsay, M.
Thangkeattiyanon, O. see Lohitnavy, M. Wong, Y.L. see Cheung, B.M.Y.
Tomlinson, B. see Critchley, J.A.J.H. Wongnawa, M. see Ridtitid, W.
Toyoda, A. see Ozaki, H. Wongpoowarak, W. see Janchawee, B.
Treluyer, J.-M., Zohar, S., Rey, E., Hubert, P., Iserin, F., Jugie, M.,
Lenclen, R., Chevret, S. & Pons, G. Minimum effective dose of
Yahyazadeh, O. see Amini, H.
midazolam for sedation of mechanically ventilated neonates, Yamaya, H., Yoshida, K., Kuritani, J., Yonezawa, J.-i., Tsuda, M.,
479 Shindo, T., Nagayama, S. & Buzdar, A.U. Safety, tolerability,
Treluyer, J.M. see Desfrere, L. and pharmacokinetics of TAS-108 in normal healthy post-
Truter, I. Methylphenidate: prescribing patterns in a South menopausal female subjects: a phase I study on single oral
African primary care patient population, 59 dose, 459
Tsao, C.-J. see Chen, S.-W. Yasumura, Y. see Saito, M.
Tsuda, M. see Yamaya, H.
Yeoh, S.F. see Hing, W.C.
Tuffin, P.H.R. see Jenkins, B.G. Yeoh, T.T. see Hing, W.C.
Yokota, S. see Fujita, T.
Yonezawa, J.-i. see Yamaya, H.
Urano, T. see Saito, M.
Yoshida, K. see Yamaya, H.
Yukawa, E., Orio, K., Yukawa, M., Terao, K. & Kinoshita, H.
Valverde, M.P. see Lukas, J.C. Population pharmacokinetic investigation of disopyramide by
Vanderbist, F. see Malonne, H. mixed effect modelling using routine clinical pharmacokinetic
Ventura, M.P., Saheb, N.E., Solari, H.P., Saraiva, V.S., Vianna, data in Japanese patients, 401
R.N.G. & Burnier Jr, M.N. Cost considerations of the new Yukawa, E., Suematsu, F., Yukawa, M. & Minemoto, M. Popu-
fixed combinations for glaucoma medical therapy, 251 lation pharmacokinetic investigation of phenobarbital by
Vial, J.H. see Jackson, S.L. mixed effect modelling using routine clinical pharmacokinetic
Vianna, R.N.G. see Ventura, M.P. data in Japanese neonates and infants, 159
Vincent, A. see Odou, P. Yukawa, E. see Fukuda, T.
Virtanen, A. see Helin-Salmivaara, A. Yukawa, M. see Yukawa, E.
Yun, H.-Y., Yun, M.-H., Kang, W. & Kwon, K.-I. Pharmacoki-
Wang, C. see Chung, L. netics and pharmacodynamics of benidipine using a slow
Wang, R. see Chen, K. receptor-binding model, 541
Yun, H.-Y. see Kang, W.K.
Wang, S.-Q. see Chen, K.
Watson, D.G. see Hebron, Y. Yun, M.-H. see Yun, H.-Y.
Watson, K. see Agnew, L.L.
Wazaify, M., Kennedy, S., Hughes, C.M. & McElnay, J.C. Zohar, S. see Desfrere, L
Prevalence of over-the-counter drug-related overdoses at Zohar, S. see Treluyer, J.-M.
© 2005 Blackweil Publishing Ltd, Journal of Clinical Pharmacy and Therapeutics, 30, 627-631